
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of BioVie (NASDAQ:BIVI) through any online brokerage.
Other companies in BioVie’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
BioVie has a consensus price target of $4.00.
The stock price for BioVie (NASDAQ: BIVI) is $2.2313 last updated September 2, 2026 at 8:42 AM EDT.
There are no upcoming dividends for BioVie.
BioVie does not have any upcoming earnings scheduled.
There is no upcoming split for BioVie.
BioVie is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.